The purpose was to define the developing role and state-of-the-art development of short-lived radionuclides (SLR's) in current nuclear medical practice. Special emphasis was placed on radionuclides with general-purpose labeling capabilities. The need for high-purity labeling-grade iodine-123 was emphasized in the program. Papers have been separately abstracted for the data base. (ACR)
OSTI Identifier 5655417 Research organization: Food and Drug Administration, Rockville, MD (USA). Center for Devices and Radiological Health. Research organization: USDOE Office of Energy Research, Washington, DC. Office of Health and Environmental Research.